Download PDF

Spheria Australian Microcap Fund

ARSN 611 819 651 APIR WHT0066AU

Performance

1 Spheria Australian Microcap Fund. Returns of the Fund are net of applicable fees, costs and taxes.
2 Benchmark is the S&P/ASX Small Ordinaries Accumulation Index.
3 Inception date is 16 May 2016. Past performance is not a reliable indicator of future performance. All p.a. returns are annualised.
a Microcap Index refers to S&P/ASX Emerging Companies Accumulation Index.

Overall Commentary

The Fund returned 4.3% (after fees) for the month of March, underperforming the S&P-ASX Small Ordinaries Accumulation Index by 0.5%.

Top 5 Holdings

Market Cap Bands

Source: Spheria Asset Management

Active Sector Exposure

Source: Spheria Asset Management

Markets

The “everything” rally continued in March with the small and microcap indices outperforming the larger cap indices for the first time in a long time. Generally, we find these markets very difficult as valuation discipline is far outweighed by fever-pitched speculation. However, this time we managed to largely keep up with the index. This is a great result considering the two best performers for the benchmark in the month were Mesoblast (MSB) and Life360 (360) which rallied 88% and 60%, respectively – two companies which we are unlikely to ever own given the former is a serial cash burner and the latter has a significant market capitalisation (nearly $3bn) despite it never being profitable. Also, the gold sector was strong as gold prices continued to surge to new highs. We have no direct gold exposure, so this was another headwind for performance. Interestingly, there were no real stand-out moves in our portfolio with the portfolio gain due to a broad-based rally across our holdings and not having anything blow-up.

Major Contributors to Performance

Over the month the largest contributors to performance were from overweight positions in Vista Group International (VGL.ASX, +20%), Jupiter Mines (JMS.ASX, +25%), and Universal Store Holdings (UNI.ASX, +16%)

Vista Group International (VGL.ASX) share price rose 20% in March post the company announcing their full year result at the end of February. Recurring revenue and SaaS revenue grew 10% and 20%, respectively, whilst EBITDA grew 25% although the company continues to capitalise an elevated level of R&D in respect of its cloud transformation. The cloud rollout continues to gather momentum with its first multi-territory client live and several new signings representing ~350 sites out of the group’s approximate 7,800 sites. The business also reaffirmed medium term aspirations of Annualised Recurring Revenue (ARR) of $175m and an EBITDA margin of 15%+ by the end of CY25, and to be free cash flow positive in Q424. We have been a long-term shareholder of Vista attracted to its strong market share (>50% ex-China) and transition from on-premise to cloud revenue which will increase their share of wallet and therefore drive significant growth in revenue and earnings.

Major Detractors from Performance

The largest detractors from performance included overweight positions in Adore Beauty (ABY.ASX, -7%), Mader Group (MAD.ASX, -9%) and Seven West Media (SWM.ASX, -10%)

Adore Beauty (ABY.ASX) share price fell 7% in March on no company specific news. The company delivered their 1H24 results in February with revenue returning to growth, supported by record average order values and an increase in returning customers. Returning customers represented 81% of sales in the first half and highlighted the loyalty of ABY’s customer base. The company generated positive earnings and free cash flow in 1H24 (although seasonally a stronger period) supported by the revenue growth, cost optimisation and re-investment in margin expansion initiatives (marketing revenue on site, further adoption of their app which is higher margin). The 2H24 has also started strongly with revenue growing 8% in the first 8 weeks, despite a challenging retail environment. The business has a net cash balance sheet representing ~30% of its market cap and trades on <0.5x EV/Sales, which is incredibly cheap on an absolute basis and relative to global peers.

Outlook & Strategy Going Forward

Investor confidence is high, and equity is cheap whilst debt is relatively expensive but available and the outlook for interest rate settings is down. We think this sets the market up for further M&A as organic growth is increasingly difficult to come by. Historically, we have been a disproportionate beneficiary of such activity as our companies are highly cash generative, have strong market positions and are generally cheaper given our valuation discipline, thus making them targets for bigger listed players, foreign companies and private equity.

Platform Availability List

If a fund is not available on your preferred platform, please contact us. Please check with your platform for minimum investment requirements and fees.

Acclaim Wealth

Asgard

BT Panorama

DASH

DPM

HUB24

Insignia Expand

IOOF Portfolio Service

Macquarie Wrap

mFund

MLC Navigator

MLC Wrap

Netwealth

OneVue

PowerWrap (IDPS Only)

Praemium

Premium Choice

Spheria Australian Microcap Fund value
Benchmark S&P/ASX Small Ordinaries Accumulation Index
Investment Objective The Fund aims to outperform the S&P/ASX Small Ordinaries Accumulation Index over the medium to long term
Suggested Minimum Investment Timeframe 5 years or more
Investing Universe Primarily listed companies on the ASX and New Zealand Stock Exchange with a market capitalisation less than A$500m at time of initial purchase
Suitable Investor Profile This product is intended for use as a minor allocation for a consumer who is seeking capital growth and has a very high risk and return profile for that portion of their investment portfolio. It is likely to be consistent with the financial situation and needs of a consumer with a 7-year investment timeframe and who is unlikely to need to withdraw their money on less than one week’s notice.
Risk Very high
Holdings Generally 20-65 stocks
Distributions Annually
Fees 1.35% p.a. management fee & 20% performance fee of the Fund’s excess return versus its benchmark, net of the management fee
Portfolio Allocation1 80-100% Australian and New Zealand equities
0-20% cash and cash equivalents
Expected Turnover 20% - 40%
Style Long only
APIR WHT0066AU
Minimum Initial Investment $25,000

Fund Ratings

Further Information

For more information, please contact Pinnacle Investment Management Limited
on 1300 010 311 or email distribution@pinnacleinvestment.com

Disclaimer

This communication is prepared by Spheria Asset Management Pty Limited (‘Spheria’) (ABN 42 611 081 326, Corporate Authorised Representative No. 1240979) as the investment manager of the Spheria Australian Microcap Fund (ARSN 611 819 651) (the ‘Fund’). Pinnacle Fund Services Limited (‘PFSL’) (ABN 29 082 494 362, AFSL 238371) is the product issuer of the Funds. PFSL is not licensed to provide financial product advice. PFSL is a wholly-owned subsidiary of the Pinnacle Investment Management Group Limited (‘Pinnacle’) (ABN 22 100 325 184). The Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the Fund are available via the links below. Any potential investor should consider the PDS and TMD before deciding whether to acquire, or continue to hold units in, the Fund.

Link to the Product Disclosure Statement

Link to the Target Market Determination

For historic TMD’s please contact Pinnacle client service Phone 1300 010 311 or Email service@pinnacleinvestment.com

This communication is for general information only. It is not intended as a securities recommendation or statement of opinion intended to influence a person or persons in making a decision in relation to investment. It has been prepared without taking account of any person’s objectives, financial situation or needs. Any persons relying on this information should obtain professional advice before doing so. Past performance is for illustrative purposes only and is not indicative of future performance. Unless otherwise specified, all amounts are in Australian Dollars (AUD).

Whilst Spheria, PFSL and Pinnacle believe the information contained in this communication is reliable, no warranty is given as to its accuracy, reliability or completeness and persons relying on this information do so at their own risk. Subject to any liability which cannot be excluded under the relevant laws, Spheria, PFSL and Pinnacle disclaim all liability to any person relying on the information contained in this communication in respect of any loss or damage (including consequential loss or damage), however caused, which may be suffered or arise directly or indirectly in respect of such information. This disclaimer extends to any entity that may distribute this communication.

Any opinions and forecasts reflect the judgment and assumptions of Spheria and its representatives on the basis of information available as at the date of publication and may later change without notice. Any projections contained in this presentation are estimates only and may not be realised in the future. Unauthorised use, copying, distribution, replication, posting, transmitting, publication, display, or reproduction in whole or in part of the information contained in this communication is prohibited without obtaining prior written permission from Spheria. Pinnacle and its associates may have interests in financial products and may receive fees from companies referred to during this communication.
This may contain the trade names or trademarks of various third parties, and if so, any such use is solely for illustrative purposes only. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with, endorsement by, or association of any kind between them and Spheria.

Zenith Disclaimer: The Zenith Investment Partners (‘Zenith’) (ABN 27 103 132 672, AFSL 226872) rating (assigned Spheria Australian Microcap Fund – February 2024) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.

Lonsec Disclaimer: The Lonsec rating (Spheria Australian Microcap Fund issued September 2023) presented in this document is published by Lonsec Research Pty Ltd (‘Lonsec’) (ABN 11 151 658 561, AFSL 421445). The Rating is limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial products. Past performance information is for illustrative purposes only and is not indicative of future performance. They are not a recommendation to purchase, sell or hold Affiliate Name products, and you should seek independent financial advice before investing in these products. The Ratings are subject to change without notice and Lonsec assumes no obligation to update the relevant documents following publication. Lonsec receives a fee from the Fund Manager for researching the products using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at: https://www.lonsec.com.au/investment-product-ratings/.